Tested Applications
| Positive WB detected in | HEK-293T cells, λ phosphatase treated HEK-293T cells |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:1000-1:4000 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
81812-4-RR targets Phospho-4EBP1 (Thr37) in WB, ELISA applications and shows reactivity with human samples.
| Tested Reactivity | human |
| Cited Reactivity | human, rat, pig |
| Host / Isotype | Rabbit / IgG |
| Class | Recombinant |
| Type | Antibody |
| Immunogen |
Peptide Predict reactive species |
| Full Name | eukaryotic translation initiation factor 4E binding protein 1 |
| Calculated Molecular Weight | 118 aa, 12 kDa |
| Observed Molecular Weight | 15-20 kDa |
| GenBank Accession Number | BC004459 |
| Gene Symbol | EIF4EBP1 |
| Gene ID (NCBI) | 1978 |
| RRID | AB_3670507 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Protein A purification |
| UNIPROT ID | Q13541 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Background Information
4EBP1 (4E-BP1) is a translational regulator and functions by sequestering eukaryotic translation initiation factor 4E (eIF4E) from the translation initiation machinery. 4E-BP1 contains at least six phosphorylation sites (Thr37, Thr46, Ser65, Thr70, Ser83, and Ser112), four of which (Thr37, Thr46, Ser65, and Thr70) are known to be regulated by mTOR signaling. Phosphorylation of Thr37 and Thr46 is thought to prime 4E-BP1 for sequential phosphorylation of Ser65 and Thr70, which results in the dissociation of 4E-BP1 from eIF4E. (PMID: 12747827)
Protocols
| Product Specific Protocols | |
|---|---|
| WB protocol for Phospho-4EBP1 (Thr37) antibody 81812-4-RR | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
Phospho-4EBP1 (Thr37) Recombinant monoclonal antibody (catalog 81812-4-RR, Proteintech) has 9 total citations. It appears in journals including Biomaterials, Lipids Health Dis, Int J Mol Sci, Transl Oncol, Exp Neurol, Mol Cell Biochem, Pathol Res Pract, Front Vet Sci, and Burns Trauma. The associated research fields span oncology (glioblastoma, triple-negative breast cancer, lung cancer, diffuse large B-cell lymphoma), metabolism and obesity, ischemic stroke rehabilitation, piglet birth weight, and diabetic wound healing. Western blotting is the predominant application across human, rat, and pig samples.
| Species | Application | Title |
|---|---|---|
Biomaterials mTOR-siRNA-conjugated and Gboxin-loaded micelles for mitochondrial dysfunction-driven synergistic glioblastoma therapy. | ||
Lipids Health Dis Imidazole propionate ameliorates lipid metabolism in adipocytes to attenuate high-fat diet-induced obesity via PPAR signaling pathway. | ||
Int J Mol Sci SCAMP3-Driven Regulation of ERK1/2 and Autophagy Phosphoproteomics Signatures in Triple-Negative Breast Cancer. | ||
Transl Oncol Next-generation sequencing in early-stage multiple primary lung cancer: The prognostic significance of genomic accumulation status and BCL2L11del | ||
Exp Neurol Optimizing functional recovery after acute ischemic stroke through intensity and frequency of rehabilitation: The critical role of HIF-1α/PLD2/mTOR signaling mechanisms. | ||
Mol Cell Biochem MELK inhibits cuproptosis in diffuse large B-cell lymphoma cells via the PI3K/mTOR/S6K-DLAT signaling axis. |

